A simple and efficient one-pot synthesis of Fmoc/Boc/Z-amino acid derived 2-amino-1,3-selenazoles by the condensation of N α -urethane protected amino acid derived bromomethyl ketones with selenourea under the influence of ultrasound has been described. Insertion of 2-amino-1,3-selenazole moiety in the side chains of Asp and Glu has also been achieved following the similar protocol.
Introduction
The growing impact of organoselenium compounds in recent years has played a key role in synthetic chemistry serving versatile and useful reagents. 1 The quest for the synthesis of selenium containing compounds can be attributed to their interesting reactivity and potential biological activity. The medicinal properties of selenium derivatives are being intensively investigated in the light of their antiviral, antitumour, antimicrobial and fungicidal properties. 2 A number of biologically active compounds such as selenoamino acids, 3 selenopeptides 4 and selenocarbohydrates 5 have been prepared and subjected to biological screening owing to their structure-biological activity relationship studies. Additionally, organoselenium compounds have emerged as an exceptional class of structures that exemplify a role in biochemical processes, serving as important therapeutic agents ranging from antiviral, anticancer agents to naturally occurring food supplements. 6 In cancer prevention, 7 selenium analogs appear to be more active than their sulfur counterparts. Selenium derivatives also exhibit antioxidant and radio-protecting activity 8 and are free radical scavengers. 9 A prominent example is glutathione peroxidase, a key enzyme in antioxidant defense system 10 that contains selenium atom in its active domain.
Selenoproteins occur widely in nature, a number of which have been isolated and characterized. 11 Typically in these molecules, selenium occurs as selenocysteine, 12 considered chlorooxiranes which are isomeric with α-chloro carbonyl compounds. 23 1,3,4-Selenadiazoles have been prepared by the reaction of potassium selenocyanate with hydazonoyl bromide. 24 Oxidation of aryl selenoamides with N-bromosuccinimide and iodine yielded 1,2,4-selenadiazoles. 25 Some of the disadvantages such as basic conditions, longer reaction duration and low yields limit the applicability of these methods. Selenourea is a convenient starting material for the synthesis of 2-amino-1,3-selenazoles. 26 Rama Rao et al., reported an efficient method for the synthesis of 1,3-selenazoles using bromomethyl ketones and selenourea in the presence of β-cyclodextrin in water. 27 Burger et al., reported the synthesis of 3-(selenazol-4-yl)alanine derivatives from hexafluroacetone protected aspartic acid in which 1,3-selenazoles were prepared by coupling selenourea to the side chain derived bromomethyl ketones under reflux conditions for 6 h. 28 Our group is interested in the incorporation of heterocycles in amino acids as well as peptides. Recently, we reported the efficient synthesis of tetrazole analogues of amino acids, 29 1,2,4-oxadiazole 30 and thiazole linked orthogonally urethane protected dipeptide mimetics. 31 With an aim to demonstrate the utility of N α -urethane protected bromomethyl ketones, the synthesis of 2-amino-1,3-selenazole analogues of amino acids was undertaken. A simple conversion of N-protected-α-amino acid derived diazomethyl ketones into the corresponding bromomethyl ketones was achieved through acidolysis with 45% aqueous HBr. The resulting intermediates were coupled with selenourea using ultrasonication. An eco-friendly and operationally simple, ultrasound irradiation which imparts high energy into molecules offers many advantages over conventional methods with substantial improvement in terms of reactivity and yield. The reaction was rapid and high yielding. The protocol was then extended for the preparation of unnatural amino acids containing 2-amino-1,3-selenazole moiety in side chains as well. To the best of our knowledge, this is the first report on the synthesis of α-carboxy modified 1,3-selenazole derivatives of amino acids.
Results and Discussion
In a typical reaction, N-Fmoc/Boc/Z-amino acid was converted into the corresponding diazomethyl ketone. This precursor was dissolved in THF, to which 45% aqueous HBr was added and the reaction was monitored through TLC and IR. Conversion of diazomethyl ketone into bromomethyl ketone was observed within 10 min through the disappearance of distinct IR peak at about 2100 cm -1 corresponding to the reactant and appearance of the characteristic strong peak of bromomethyl ketone at around 1735 cm -1 . The resulting bromomethyl ketone (Scheme 1)
was obtained in near quantitative yield by diluting the reaction mixture with water. It is notable that the protocol is devoid of any workup procedure. N-Protected bromomethyl ketones were obtained in pure form by single crystallization from THF-water mixture. All the bromomethyl ketones were obtained as stable solids and could be stored for long time without any degradation. They were completely characterized and were found to match with the reports in the literature after comparison. 
Scheme 1
Further, the 2-amino-1,3-selenazole analogues of Fmoc/Boc/Z-amino acids (Scheme 2) were prepared upon treating the bromomethyl ketones with selenourea through the application of Hantzsch protocol and subjected to ultrasonication using acetone as reaction solvent. The reaction was rapid as evident by the disappearance of bromomethyl ketone peak at around 1735 cm -1 in IR spectrum and the reaction was found to be complete in 10 min. Solvent was evaporated under reduced pressure and isolated crude 2-amino-1,3-selenazole derivatives were purified by column chromatography using CHCl 3 /MeOH (9:1) system and completely characterized ( Table 1) . Next, the current protocol was examined for racemization through NMR analysis. The study was carried out by preparing the selenazole derivatives 4 from the For the insertion of 2-amino-1,3-selenazole moiety in the side chain of amino acids, the side chain carboxyl group of Asp/Glu was converted to the corresponding bromomethyl ketone using oxazolidinone as a key intermediate. N α -Protected oxazolidinones were prepared in high yields employing microwave assisted synthesis 33 starting from N α -Fmoc/Z-amino acids and converted into diazomethyl ketones through the corresponding mixed anhydrides. The diazomethyl ketones were hydrolyzed with aqueous hydrobromic acid to obtain bromomethyl ketones in good yields and purity (Scheme 3). The resulting compounds were treated with selenourea in acetone and subjected to ultrasound waves for 10 min. 2-Amino-1,3-selenazole moiety was successfully incorporated in the side chains of Asp/Glu oxazolidinones. Compared to a previous report, the current protocol is rapid employing milder reaction conditions. 28 The oxazolidinone ring was selectively saponified with 1N LiOH to obtain the side chain products in good yields. Further, the amino group in the selenazole ring was orthogonally protected using Boc-urethane group. Then, the chain extension along C-terminus was demonstrated by coupling the ω-selenazole containing α-carboxylic acid with hydrochloride salt of amino acid ester resulting in a peptide in good yield and purity (Scheme 3, Table 2 ). 
Conclusions
In conclusion, a simple route for the synthesis of N α -urethane protected amino acid derived 2-amino-1,3-selenazoles employing Fmoc/Boc/Z-protected bromomethyl ketones as key intermediates under ultrasonic conditions is developed. The method is also extended in inserting the selenazole moiety in side chains of Asp and Glu. Further, orthogonal protection of amino group enabled the peptide chain extension. H spin-spin coupling constants were carried out from the proton-coupled 77 Se NMR spectra in Me 2 Se/CDCl 3 , at 76 MHz. Mass spectra were recorded using high resolution mass spectrometer and the samples were dried under vacuum before analysis. The ultrasound bath (Elma, T 310/H) was German made and operated at 35 kHz. Unless or otherwise mentioned, all amino acids used have L-configuration. TLC analysis was carried out using the pre-coated silica gel G 254 plates.
General

General procedure for the preparation of N α -Fmoc/Boc/Z-protected diazomethyl ketones
To a stirred solution of N α -protected amino acid (10 mmol) in THF at -15 o C, was added TEA (1.1 mL, 10 mmol) and ethyl chloroformate (0.91 mL, 10 mmol) and stirring was continued for another 15 min at the same temperature, then diazomethane in ether (10 mL) was added at 0 ºC and stirred for 30 min. The solvent was evaporated and the residue was dissolved in CH 2 Cl 2 and washed successively with 10% NaHCO 3 (10 mL), 10% hydrochloric acid (10 mL) or 10% citric acid (in case of Boc-amino acids), water (10 mL) and brine solution. The organic layer was dried over sodium sulphate and concentrated to yield the desired product.
General procedure for the preparation of N α -Fmoc/Boc/Z-protected bromomethyl ketones To the amino acid derived diazomethyl ketone (10 mmol) in THF was added 2-3 mL of 45% aq. HBr solution at room temperature and stirring was continued for another 5 min till the starting material was completely consumed. The reaction mixture was diluted with excess of water and the precipitated solid was filtered. The product was purified by crystallization using THF-water mixture.
General procedure for the preparation of 2-amino-1,3-selenazole derivatives of Fmoc/Boc/Z-amino acids To a solution containing 10 mmol of N α -urethane protected amino acid derived bromomethyl ketone was added selenourea dissolved in acetone and the reaction mixture was subjected to sonication for 10 min. After the complete disappearance of the reactant (as monitored by TLC), the solvent was evaporated in vacuo and the residue was dissolved in THF. To this, 10 mmol (1.7 mL) of triethylamine was added and the resulting HBr salt of triethylamine was filtered. The filtrate was evaporated under vacuum and the residue was purified by column chromatography using CHCl 3 /MeOH (9:1) system. Fluoren-9-yl)methyl 1-(2-amino-1,3-selenazol-4-yl) Fluoren-9-yl)methyl 1-(2-amino-1,3-selenazol-4-yl)-2-methylpropylcarbamate (4c) 1-(2-amino-1,3-selenazol-4-yl)-2-phenylethylcarbamate (4i) 1-(2-amino-1,3-selenazol-4-yl) Fluoren-9-yl)methyl 4-[(2-amino-1,3-selenazol-4-yl) 4-[2-(2-amino-1,3-selenazol-4-yl)ethyl]-5-oxooxazolidine-3-carboxylate (7d) 2-[2-(benzyloxycarbonyl)-3-[2-(tert-butoxycarbonyl)-1,3-selenazol-4 
The characterization data for N-protected bromomethyl ketones (9H-Fluoren-9-yl)methyl 1-(benzyloxy)-4-bromo-3-oxobutan-2-ylcarbamate (3e
